Target (CBDY) Equity Income (2020 - 2023)
Target (CBDY) reported Equity Income of $68115.0 for Q2 2023, down 35.08% year-over-year from $104923.0 in Q2 2022, and up 254.94% quarter-over-quarter from -$43963.0 in Q1 2023.
Target (CBDY) Equity Income (2020 - 2023) Analysis & Trends
Target (CBDY) has 4 years of Equity Income data on file, last reported at $68115.0 in Q2 2023.
- Equity Income for Q2 2023 came in at $68115.0, down 35.08% year-over-year; the trailing twelve-month figure through Dec 2023 was $24152.0 (down 93.19% YoY), and the FY2023 annual result was $24152.0, down 93.19% from the prior year.
- Equity Income improved to $68115.0 in Q2 2023 per CBDY's latest filing, from -$43963.0 in the prior quarter.
- Over five years, Equity Income peaked at $161663.0 in Q4 2020 and troughed at -$280916.0 in Q3 2020.
- A 4-year average of -$10984.0 and a median of $36787.0 in 2021 frame the typical range for Equity Income.
- The sharpest annual moves came in 2021 and 2022: Equity Income slumped 263.94% in 2021, then surged 508.19% in 2022.
- A 4-year view of Equity Income shows it stood at $161663.0 in 2020, then tumbled by 263.94% to -$265024.0 in 2021, then surged by 141.46% to $109869.0 in 2022, then plunged by 38.0% to $68115.0 in 2023.
- Business Quant data shows CBDY's Equity Income at $68115.0 in Q2 2023, -$43963.0 in Q1 2023, and $109869.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -1.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 25.30 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 14.91 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -9.68 Mn |
| 10 | Target | - | - | 191,787.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 68,115.00 |
| Mar 31, 2023 | -43,963.00 |
| Dec 31, 2022 | 109,869.00 |
| Sep 30, 2022 | 93,819.00 |
| Jun 30, 2022 | 104,923.00 |
| Mar 31, 2022 | 46,125.00 |
| Dec 31, 2021 | -265,024.00 |
| Sep 30, 2021 | -33,458.00 |
| Jun 30, 2021 | 36,787.00 |
| Mar 31, 2021 | -11,300.00 |
| Dec 31, 2020 | 161,663.00 |
| Sep 30, 2020 | -280,916.00 |
| Jun 30, 2020 | -129,432.00 |